SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-039459
Filing Date
2004-03-12
Accepted
2004-03-11 21:09:38
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR YEAR END 12/31/2003 d10k.htm 10-K 1196860
3 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex121.htm EX-12.1 18853
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 1002
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2098
6 SECTION 302 CERTIFICATION FOR CEO dex311.htm EX-31.1 10393
7 SECTION 302 CERTIFICATION FOR CFO dex312.htm EX-31.2 10612
8 SECTION 906 CERTIFICATION dex32.htm EX-32 7117
  Complete submission text file 0001193125-04-039459.txt   1249126
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 04664056
SIC: 2834 Pharmaceutical Preparations